UM LAPs- U10 Grant

UM LAP- U10 补助金

• 批准号: 9032463
• 负责人: MARK M ZALUPSKI
• 金额: $ 68.27万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-15 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9032463
• 关键词: Adjuvant Therapy; Adoption; Adult; Award; Basic Science; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Collaborations; Collection; Comprehensive Cancer Center; Data; Data Quality; Development; Discipline; Enrollment; Ethics; Faculty; Goals; Grant; Health; Healthcare Systems; Institution; Laws; Lead; Leadership; Malignant Neoplasms; Mentors; Michigan; Modality; National Clinical Trials Network; Patient-Focused Outcomes; Patients; Policies; Postdoctoral Fellow; Process; Prognostic Factor; Protocol Compliance; Protocols documentation; Research; Role; Schools; Site; Toxic effect; Training; Universities; anticancer research; cancer therapy; data management; improved; medical schools; operation; response; therapy outcome

DESCRIPTION (provided by applicant): The University of Michigan (UM), inclusive of its Comprehensive Cancer Center (UMCCC) and Medical School Departments, requests its inaugural UI0 award as an NCI National Clinical Trials Network Lead Academic Participating Site (NCTN LAPS-U10). We view this opportunity as an important component of a large cancer research effort at our institution. We remain committed to the concept that multi-institutional collaboration is essential to the advancement of cancer treatment. Our goal as a LAP Site is to make significant scientific, administrative and patient data contributions to the NCTN effort to study and improve cancer therapy. The NCTN process involves the collection of patient data, adoption of uniform toxicity and response criteria, and conduction of purposeful clinical trials. Cooperative group research is the only setting in which sophisticated concepts of combined modality and interdisciplinary therapy as well as adjuvant therapies can be properly evaluated. The cooperative groups have also provided improved understanding of the important relationships between prognostic factors, therapy and patient outcomes that could not have been obtained otherwise.

描述（由申请人提供）：密歇根大学（UM），包括其综合癌症中心（UMCCC）和医学院部门，请求其就职UI0奖作为NCI国家临床试验网络领先的学术参与站点（NCTN LAPS-U10）。我们将这个机会视为我们机构进行大型癌症研究工作的重要组成部分。我们仍然致力于这样一个概念，即多机构合作对于癌症治疗的发展至关重要。我们作为膝盖站点的目标是为NCTN研究和改善癌症疗法做出重要的科学，行政和患者数据贡献。 NCTN过程涉及收集患者数据，采用均匀毒性和反应标准以及有目的的临床试验。合作小组研究是唯一可以正确评估合并方式和跨学科疗法以及辅助疗法的复杂概念的唯一环境。合作群体还提供了对预后因素，治疗和患者结局之间重要关系的理解，否则无法获得。